{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:32:11Z","timestamp":1790404331401,"version":"4.1.0"},"reference-count":31,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Pathogenic variants in SCN5A, the gene encoding the cardiac Na+ channel \u03b1-subunit Nav1.5, result in life-threatening arrhythmias, e.g., Brugada syndrome, cardiac conduction defects and long QT syndrome. This variety of phenotypes is underlied by the fact that each Nav1.5 mutation has unique consequences on the channel trafficking and gating capabilities. Recently, we established that sodium channel \u03b1-subunits Nav1.5, Nav1.1 and Nav1.2 could dimerize, thus, explaining the potency of some Nav1.5 pathogenic variants to exert dominant-negative effect on WT channels, either by trafficking deficiency or coupled gating. Objective: The present study sought to examine whether Nav1.5 channels can cooperate, or transcomplement each other, to rescue the Na+ current (INa). Such a mechanism could contribute to explain the genotype-phenotype discordance often observed in family members carrying Na+-channel pathogenic variants. Methods: Patch-clamp and immunocytochemistry analysis were used to investigate biophysical properties and cellular localization in HEK293 cells and rat neonatal cardiomyocytes transfected respectively with WT and 3 mutant channels chosen for their particular trafficking and\/or gating properties. Results: As previously reported, the mutant channels G1743R and R878C expressed alone in HEK293 cells both abolished INa, G1743R through a trafficking deficiency and R878C through a gating deficiency. Here, we showed that coexpression of both G1743R and R878C nonfunctioning channels resulted in a partial rescue of INa, demonstrating a cooperative trafficking of Nav1.5 \u03b1-subunits. Surprisingly, we also showed a cooperation mechanism whereby the R878C gating-deficient channel was able to rescue the slowed inactivation kinetics of the C-terminal truncated R1860X (\u0394Cter) variant, suggesting coupled gating. Conclusions: Altogether, our results add to the evidence that Nav channels are able to interact and regulate each other\u2019s trafficking and gating, a feature that likely contributes to explain the genotype-phenotype discordance often observed between members of a kindred carrying a Na+-channel pathogenic variant.<\/jats:p>","DOI":"10.31083\/j.fbl2707209","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T02:32:54Z","timestamp":1656642774000},"source":"Crossref","is-referenced-by-count":7,"title":["Trafficking and Gating Cooperation Between Deficient Nav1.5-mutant Channels to Rescue INa"],"prefix":"10.31083","volume":"27","author":[{"given":"J\u00e9r\u00f4me","family":"Clatot","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, 75013 Paris, France"},{"name":"Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA"},{"name":"The Epilepsy NeuroGenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Coulombe","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desch\u00eanes","sequence":"first","affiliation":[{"name":"Department of Physiology and Cell Biology, Frick Center for Heart Failure and Arrhythmias, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Guicheney","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Neyroud","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wilde AAM, Amin AS. Clinical Spectrum of SCN5a Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy. JACC: Clinical Electrophysiology. 2018; 4: 569\u2013579.","DOI":"10.1016\/j.jacep.2018.03.006"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Keller DI, Rougier J-S, Kucera JP, Benammar N, Fressart V, Guicheney P, et al. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovascular Research. 2005; 67: 510\u2013519.","DOI":"10.1016\/j.cardiores.2005.03.024"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Clatot J, Ziyadeh-Isleem A, Maugenre S, Denjoy I, Liu H, Dilanian G, et al. Dominant-negative effect of SCN5a N-terminal mutations through the interaction of Nav1.5 \u03b1-subunits. Cardiovascular Research. 2012; 96: 53\u201363.","DOI":"10.1093\/cvr\/cvs211"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hoshi M, Du XX, Shinlapawittayatorn K, Liu H, Chai S, Wan X, et al. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations. Circulation. Cardiovascular Genetics. 2014; 7: 123\u2013131.","DOI":"10.1161\/CIRCGENETICS.113.000292"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Doisne N, Grauso M, Mougenot N, Clergue M, Souil C, Coulombe A, et al. In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant. Frontiers in Physiology. 2021; 12: 661413.","DOI":"10.3389\/fphys.2021.661413"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Zheng Y, Wan X, Yang D, Ramirez-Navarro A, Liu H, Fu J-D, et al. A Heart Failure-Associated SCN5A Splice Variant Leads to a Reduction in Sodium Current Through Coupled-Gating With the Wild-Type Channel. Frontiers in Physiology. 2021; 12: 661429.","DOI":"10.3389\/fphys.2021.661429"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zhang Z, Barajas-Mart\u00ednez H, Xia H, Li B, Capra JA, Clatot J, et al. Distinct Features of Probands with Early Repolarization and Brugada Syndromes Carrying SCN5a Pathogenic Variants. Journal of the American College of Cardiology. 2021; 78: 1603\u20131617.","DOI":"10.1016\/j.jacc.2021.08.024"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"O\u2019Neill MJ, Muhammad A, Li B, Wada Y, Hall L, Solus JF, et al. Dominant negative effects of SCN5A missense variants. bioRxiv. 2021; 2021.09.22.461398.","DOI":"10.1101\/2021.09.22.461398"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wang Z, Vermij SH, Sottas V, Shestak A, Ross-Kaschitza D, Zaklyazminskaya EV, et al. Calmodulin binds to the N-terminal domain of the cardiac sodium channel Nav1.5. Channels. 2020; 14: 268\u2013286.","DOI":"10.1080\/19336950.2020.1805999"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Clatot J, Hoshi M, Wan X, Liu H, Jain A, Shinlapawittayatorn K, et al. Voltage-gated sodium channels assemble and gate as dimers. Nature Communications. 2017; 8: 2077.","DOI":"10.1038\/s41467-017-02262-0"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Clatot J, Zheng Y, Girardeau A, Liu H, Laurita KR, Marionneau C, et al. Mutant voltage-gated Na+ channels can exert a dominant negative effect through coupled gating. American Journal of Physiology-Heart and Circulatory Physiology. 2018; 315: H1250\u2013H1257.","DOI":"10.1152\/ajpheart.00721.2017"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang T, Ma A, Zhou X, Gui J, Wan H, et al. Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel. Acta Physiologica. 2008; 194: 311\u2013323.","DOI":"10.1111\/j.1748-1716.2008.01883.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Gui J, Wang T, Jones RPO, Trump D, Zimmer T, Lei M. Multiple loss-of-function mechanisms contribute to SCN5a-related familial sick sinus syndrome. PLoS ONE. 2010; 5: e10985.","DOI":"10.1371\/journal.pone.0010985"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Valdivia CR, Tester DJ, Rok BA, Porter CJ, Munger TM, Jahangir A, et al. A trafficking defective, Brugada syndrome-causing SCN5a mutation rescued by drugs. Cardiovascular Research. 2004; 62: 53\u201362.","DOI":"10.1016\/j.cardiores.2004.01.022"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Remme CA. Cardiac sodium channelopathy associated withSCN5Amutations: electrophysiological, molecular and genetic aspects. The Journal of Physiology. 2013; 591: 4099\u20134116.","DOI":"10.1113\/jphysiol.2013.256461"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Poelzing S, Forleo C, Samodell M, Dudash L, Sorrentino S, Anaclerio M, et al. SCN5a polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation. 2006; 114: 368\u2013376.","DOI":"10.1161\/CIRCULATIONAHA.105.601294"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Shinlapawittayatorn K, Dudash LA, Du XX, Heller L, Poelzing S, Ficker E, et al. A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5a mutations. Circulation. Cardiovascular Genetics. 2011; 4: 500\u2013509.","DOI":"10.1161\/CIRCGENETICS.111.960633"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Cormet-Boyaka E, Jablonsky M, Naren AP, Jackson PL, Muccio DD, Kirk KL. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 8221\u20138226.","DOI":"10.1073\/pnas.0400459101"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Owsianik G, Cao L, Nilius B. Rescue of functional DeltaF508-CFTR channels by co-expression with truncated CFTR constructs in COS-1 cells. FEBS Letters. 2003; 554: 173\u2013178.","DOI":"10.1016\/S0014-5793(03)01162-1"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Cebotaru L, Woodward O, Cebotaru V, Guggino WB. Transcomplementation by a truncation mutant of cystic fibrosis transmembrane conductance regulator (CFTR) enhances \u0394F508 processing through a biomolecular interaction. The Journal of Biological Chemistry. 2013; 288: 10505\u201310512.","DOI":"10.1074\/jbc.M112.420489"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhao X, Zhu C, Tian L, Fu Y, Zhang Y, Chen X, et al. Kv4.3 Modulates the Distribution of hERG. Scientific Reports. 2017; 7: 17757.","DOI":"10.1038\/s41598-017-17837-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gabelli SB, Boto A, Kuhns VH, Bianchet MA, Farinelli F, Aripirala S, et al. Regulation of the NaV1.5 cytoplasmic domain by calmodulin. Nature Communications. 2014; 5: 5126.","DOI":"10.1038\/ncomms6126"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Singh AK, Saotome K, Sobolevsky AI. Swapping of transmembrane domains in the epithelial calcium channel TRPV6. Scientific Reports. 2017; 7: 10669.","DOI":"10.1038\/s41598-017-10993-9"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Dixon RE, Navedo MF, Binder MD, Santana LF. Mechanisms and Physiological Implications of Cooperative Gating of Ion Channels Clusters. Physiological Reviews. 2021. (in press)","DOI":"10.1152\/physrev.00022.2021"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Aldrich RW, Corey DP, Stevens CF. A reinterpretation of mammalian sodium channel gating based on single channel recording. Nature. 1983; 306: 436\u2013441.","DOI":"10.1038\/306436a0"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circulation Research. 1992; 71: 1231\u20131241.","DOI":"10.1161\/01.RES.71.5.1231"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Naundorf B, Wolf F, Volgushev M. Unique features of action potential initiation in cortical neurons. Nature. 2006; 440: 1060\u20131063.","DOI":"10.1038\/nature04610"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"R\u00fchlmann AH, K\u00f6rner J, Hausmann R, Bebrivenski N, Neuhof C, Detro-Dassen S, et al. Uncoupling sodium channel dimers restores the phenotype of a pain-linked Nav 1.7 channel mutation. British Journal of Pharmacology. 2020; 177: 4481\u20134496.","DOI":"10.1111\/bph.15196"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hichri E, Selimi Z, Kucera JP. Modeling the Interactions Between Sodium Channels Provides Insight Into the Negative Dominance of Certain Channel Mutations. Frontiers in Physiology. 2020; 11: 589386.","DOI":"10.3389\/fphys.2020.589386"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Ishikawa T, Kimoto H, Mishima H, Yamagata K, Ogata S, Aizawa Y, et al. Functionally validated SCN5a variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. European Heart Journal. 2021; 42: 2854\u20132863.","DOI":"10.1093\/eurheartj\/ehab254"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Ziyadeh-Isleem A, Clatot J, Duchatelet S, Gandjbakhch E, Denjoy I, Hidden-Lucet F, et al. A truncating SCN5a mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation. Heart Rhythm. 2014; 11: 1015\u20131023.","DOI":"10.1016\/j.hrthm.2014.02.021"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/7\/10.31083\/j.fbl2707209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:06:57Z","timestamp":1732709217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/7\/10.31083\/j.fbl2707209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2768-6701(22)00578-0"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2707209","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"article-number":"209"}}